Patient Guide: DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 243 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06989112
Status: 🟢 Enrolling Now
Condition: Endometrial Cancer
Phase: PHASE3

Where You Can Participate

This study is available at 243 locations across the country.

Top locations include:
  • • Tucson, Arizona
  • • Little Rock, Arkansas
  • • Duarte, California
  • • And 240 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer - Join Clinical Trial NCTNCT06989112

How to Join This Clinical Trial - NCTNCT06989112

Learn how to participate in this PHASE3 trial studying an investigational therapy for Endometrial Cancer. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Endometrial Cancer. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Endometrial Cancer
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06989112 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 243 locations. Find a study site near you:

Clinical Research Site

Tucson, Arizona 85704 - United States

Status: WITHDRAWN

Clinical Research Site

Little Rock, Arkansas 72205 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Duarte, California 91010 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

La Jolla, California 92037 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Palo Alto, California 94304 - United States

Status: WITHDRAWN

Clinical Research Site

San Francisco, California 94143 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Sylmar, California 91342 - United States

Status: WITHDRAWN

Clinical Research Site

Fort Myers, Florida 33901 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Miami Beach, Florida 33140 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

St. Petersburg, Florida 33705 - United States

Status: NOT_YET_RECRUITING

And 233 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Endometrial Cancer:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships